CSIMarket Company Name, Ticker, Industry, else..
 
Transcode Therapeutics Inc   (NASDAQ: RNAZ)
Other Ticker:  
 
 

Transcode Therapeutics Inc's Customers Performance

RNAZ


 
 
RNAZ's Source of Revenues

• List of RNAZ Customers




for the same period Transcode Therapeutics Inc

• List of RNAZ Customers





Transcode Therapeutics Inc's Comment on Sales, Marketing and Customers





  News about Transcode Therapeutics Inc Contracts

Revitalizing the Fight Against Metastatic Pancreatic Cancer: TransCode Therapeutics Unveils Groundbreaking Results with TTX-MC138


:
TransCode Therapeutics, a prominent biopharmaceutical company specializing in the development of innovative therapies, has recently reported positive pre-clinical results for its lead candidate, TTX-MC138. This groundbreaking research demonstrates the effectiveness of TTX-MC138 in animal models of human metastatic pancreatic cancer. In this article, we will outline the key facts and assess the significant impact of these findings on TransCode Therapeutics.
Facts:
TransCode Therapeutics has made significant strides in the battle against metastatic pancreatic cancer by displaying exceptional efficacy with their lead candidate, TTX-MC138. The company s pre-clinical studies have successfully d...












RNAZ's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Transcode Therapeutics Inc 2.71 0.00 -16.79 10
SUBTOTAL 0.00 0.00 0.00 -


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com